Rakovina Therapeutics closes upsized private placement raising $1.99 million

• Rakovina Therapeutics closed an upsized non-brokered private placement, issuing 19,910,000 units for gross proceeds of $1.99 million.
• Final tranche raised $597,000 from 5,970,000 units priced at $0.1; first tranche raised $1.39 million from 13,940,000 units.
• Each unit includes one common share, one-half warrant; each whole warrant exercisable at $0.2 for 24 months.
• Insiders bought 2,120,000 units for $212,000, including 220,000 units for $22,000 in the final tranche.
• Proceeds earmarked for in vivo ADME and efficacy work on kt-5000AI, AI-driven lead optimization, pipeline development, working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rakovina Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608311612PRIMZONEFULLFEED9818846) on August 31, 2026, and is solely responsible for the information contained therein.